1. Home
  2. GKOS vs VNOM Comparison

GKOS vs VNOM Comparison

Compare GKOS & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$120.34

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

VNOM

Viper Energy Inc.

HOLD

Current Price

$36.85

Market Cap

6.4B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
VNOM
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.4B
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
GKOS
VNOM
Price
$120.34
$36.85
Analyst Decision
Strong Buy
Buy
Analyst Count
14
12
Target Price
$127.71
$53.36
AVG Volume (30 Days)
677.3K
2.0M
Earning Date
02-17-2026
02-23-2026
Dividend Yield
N/A
6.47%
EPS Growth
N/A
N/A
EPS
N/A
1.93
Revenue
$469,820,000.00
$1,131,200,000.00
Revenue This Year
$31.33
$58.96
Revenue Next Year
$24.01
$27.71
P/E Ratio
N/A
$19.16
Revenue Growth
30.38
42.38
52 Week Low
$73.16
$34.71
52 Week High
$163.71
$52.03

Technical Indicators

Market Signals
Indicator
GKOS
VNOM
Relative Strength Index (RSI) 64.15 43.55
Support Level $93.96 $36.19
Resistance Level $115.00 $38.92
Average True Range (ATR) 4.48 1.13
MACD -0.42 -0.05
Stochastic Oscillator 94.40 33.57

Price Performance

Historical Comparison
GKOS
VNOM

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VNOM Viper Energy Inc.

Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.

Share on Social Networks: